Abstract-Ch ro not ropic and inotropic effects of glucagon were compared with those of norepinephrine using the excised SA node and the papillary muscle preparations cross-circulated with a donor dog. Glucagon was administered i.v. to the donor dog at doses of I to 30 &mu;g/kg, which caused a marked chronotropic but less marked inotropic effect. Cardiohemodynamic response to glucagon of anesthetized dogs was simulated by an acceleration induced by atrial pacing. It was concluded that glucagon is more effective on chronotropism than on inotropism, and that its cardio hemodynamic effects are mainly ascribed to the increased heart rate.
Since glucagon-induced positive chronotropic and inotropic effects were demonstrated not only in the isolated heart preparation but also in the intact heart of different species of animals, many investigatores have attempted to clarify the mode of action. It is gener ally accepted that the enhancement of cardiac performance induced by glucagon is not mediated by 13-adrenoceptor stimulation (1, 2, 3, 4) . Recent studies suggest that its effects are due to an increase in the intracellular concentration of cyclic 3', 5'-AMP resulting from activation of adenyl cyclase (5, 6, 7) . Even at present, when glucagon has already been introduced for clinical use as a cardiotonic drug, the difference between glucagon and the adrenergic effects is not clear. In the present study, chronotropic and inotropic effects of glucagon were compared with those of norepinephrine in the excised SA node and the papillary muscle preparations cross-circulated with a donor dog, and its cardiohemody namic effects were also investigated in the whole animal.
MATERIALS AND METHODS
Mongrel dogs of both sexes were anesthetized with 30 mg/kg of sodium pentobarbital, i.v. After 200 units/kg of sodium heparin, i.v., the heart was excised and immersed into Tyrode's solution at about 4'C, equilibrated with a gas mixture consisting of 95% 02 and 5 % CO2. The excised SA node and the excised papillary muscle preparations were cross circulated by a donor dog as illustrated in a diagram (Fig. 1) . The SA node and the papil lary muscle preparations have been previously described in detail by Kubota and Hashi moto (8) and Endoh and Hashimoto (9) , respectively. Donor dogs were anesthetized with 30 mg/kg of sodium pentobarbital, i.v. Sodium heparin, 300 units/kg, was given at the beginning of the perfusion and maintenance dose of 100 units/kg was given every hour. Both preparations were perfused with the blood conducted from the left carotid artery of the donor dog by the aid of a peristaltic pump (Harvard Apparatus Co., model 500-1200). The perfusion pressure was maintained at 100 mmHg by means of Starling pneumatic resistance draining an excess blood to the left jugular vein. Changes in systemic blood pressure and heart rate of the donor dog, sinus rate of the SA node preparation and contractile force of the papillary muscle preparation were simultaneously recorded on an ink writing rectigraph (San-ei Sokki Instru Bipolar electrodes for atrial pacing were sutured on the epicardial surface on the right atrial appendix. Rectangular pulses of 1-msec duration were delivered through the elec trodes using an isolation unit (Grass, SIU4A) and an electronic stimulator (Nihon Kohden, MSE-3). Drugs used were glucagon (Novo Industri) and l-norepinephrine (Fluka AG). 
RESULTS

Comparison of chronotropic and isotropic effects
Glucagon was administered to the donor dog at doses of 1 to 30 ,reg/kg i.v. A typical result is shown in Fig. 2 . Glucagon caused a marked and long-lasting acceleration of heart rate which was accompanied by a slight decrease in systemic blood pressure in the donor dog. Sinus rate of the SA node preparation increased almost in parallel with the acceleration of heart rate of the donor dog. On the other hand, contractile force of the papillary muscle preparation hardly increased at doses of 1 to 3 ,ug/kg, and only slightly at doses of 10 to 30 pg/kg. The time-course of the response to glucagon at doses of 3 to 30 pg/kg is shown in Fig. 3 . The duration of the acceleration of sinus rate both of the SA node preparation and of the donor dog was over 40 min at doses of 10 to 30 ppg/kg. Glucagon at doses of I to 10 ,ug/kg i.v.
caused a dose-dependent acceleration of heart rate and an increase in the pulmonary arterial flow, i.e., the total cardiac output. DISCUSSION It has been recognized that glucagon possesses positive chronotropic and inotropic actions on the heart (1, 2, 10, 11). Glick (1) and Lucchesi (2) indicated that glucagon caused a dose-dependent increase in contractile force simultaneously with an acceleration of heart rate in open-chest dogs. The influence of the heart rate on the contractile force could not be eliminated under such an experimental condition, as the acceleration of heart rate secondarily induced an increase in contractile force through the mechanism of "fre quency-force relationship" characterized in the myocardium (9, 12) . In the preparation used in this study, contractile force was always measured at the fixed frequency of 120/min, and the influence of "frequency-force relationship"" could be avoided.
Glucagon caused an acceleration of sinus rate both in the SA node preparation and in the donor dog at a threshold dose of I pgjkg. On the other hand, a threshold dose of glucagon causing an increase in contractile force was 3 ,rig 'kg or more. Unlike glu cagon, norepinephrine induced an increase both in sinus rate and in contractile force simul taneously at a threshold dose of 0.1 pg~kg. The degree of the acceleration of sinus rate induced by 3 t k-(, of gfucagon was almost the same as that induced by the same dose of norepinephrine. Although norepinephrine induced about 160° increase in contractile force at a close of 3 dig kg, a glucagon-induced one was only about 40° even at a dose of 30 ; ig; kg. Comparing the etlects of glucagon with those of norepinephrine, it can be concluded that (1lucagon is more effective on chronotropism than on inotropisni.
Glucagon caused a simultaneous increase in both in cardiac output and venous re turn and a decrease in right atrial pressure. Since these card iohemodynamic responses to glucagon could be simulated by atrial pacing, it is concluded that an acceleration of heart rate produced by glucagon plays an important role in its cardiohemodynamic effects through the mechanism of "frequency-force relationship" and that direct myocardial stimu lation is only a subsidiary factor. These responses were resistant to C3-adrenergic block ing agents in these experiments.
